ZPRÁVA O PRŮBĚHU KLINICKÉHO HODNOCENÍ FAR-RMS (23. 11. 2022 – 29. 5. 2023)
| Title in English | REPORT ON THE PROGRESS OF THE FAR-RMS CLINICAL EVALUATION (23/11/2022 – 29/05/2023) |
|---|---|
| Authors | |
| Year of publication | 2023 |
| MU Faculty or unit | |
| Web | FaR-RMS |
| Description | FaR-RMS is an international, randomized, open, multicenter clinical study conducted at the University Hospital in Brno and the University Hospital in Motol. The primary objective of the study is to improve the prognosis of patients with rhabdomyosarcoma. In the Czech Republic, it will take place only in children's clinics. |